logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2010 or most recent year available

Part (iv) New hallucinogen inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium100000000000
Bulgaria00000000000
Czech Republic00100000101
Denmark00000000000
Germany00110010303
Estonia:::::::::::
Ireland00001100202
Greece00001000101
Spain:::::::::::
France:::::::::::
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary00000000000
Malta:::::::::::
Netherlands0515151062457057
Austria00000000000
Poland2:::::::::::
Portugal:::::::::::
Romania01202100606
Slovenia:::::::::::
Slovakia00000010101
Finland00000000000
Sweden00100000101
Uk300241000707
Croatia00100000101
Turkey:::::::::::
Norway:::::::::::
Total0623201584480080
 

Notes:

: Indicates no data are available.

(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were 96 Opiates, 1 Cocaine and 1 Hypnotics and Sedatives clients with the primary exact drug unknown. Of which 3 and 1 were new clients for respectively Opiates and Cocaine.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2009 to 31st March 2010.

See also 'tdi-10-p12345678-07-Age distribution summary.xls' 'partv',' partvi' and 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2011 REITOX National Reports - Table TDI Inpatient Treatment Centres

Page last updated: Monday, 09 July 2012